Back
Corporate News
Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
30-May-2025, 09:13
Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Metformin Hydrochloride 500mg/ 5 ml Oral Solution from UK Medicines & Healthcare Products Regulatory Agency.
Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketing Authorization for the product Metformin Hydrochloride 500mg/ 5 ml Oral Solution from UK Medicines & Healthcare Products Regulatory Agency.
Powered by Capital Market - Live News